Author Details

Zhukova, L G

Issue Section Title File
Vol 11, No 1 (2009) Articles Bevatsizumab (Avastin) v kombinatsii s taksanami v 1-y linii lecheniya HER-2-negativnogo metastaticheskogo raka molochnoy zhelezy(Rezul'taty issledovaniya AVADO)
Vol 11, No 1 (2009) Articles Dlitel'noe i bezopasnoe primenenie Avastina pri metastaticheskom kolorektal'nom rake: klinicheskiy opyt primeneniya
Vol 11, No 3 (2009) Articles Klinicheskaya effektivnost'i bezopasnost' primeneniya otechestvennogo rekombinantnogo granulotsitarnogo koloniestimuliruyushchego faktora Neypomaks® u bol'nykh rakom molochnoy zhelezy, poluchayushchikh khimioterapiyu doksorubitsinom i dotsetakselom
Vol 12, No 1 (2010) Articles Sovremennye aspektyprofilaktiki neytropeniipri khimioterapii solidnykh opukholey
Vol 12, No 3 (2010) Articles Bevatsizumab v lechenii HER2-negativnogometastaticheskogo raka molochnoy zhelezy:sovremennye dannye ob effektivnostii bezopasnosti
Vol 13, No 2 (2011) Articles Klinicheskie rekomendatsii po profilaktikei lecheniyu toshnoty i rvoty u bol'nykh,poluchayushchikh khimio- i luchevuyuprotivoopukholevuyu terapiyu
Vol 17, No 1 (2015) Articles The improvement in overall survival for patients with metastatic breast cancer treated with eribulin: the resolution based on results of the expert council
Vol 18, No 2 (2016) Articles Development of cytotoxic chemotherapy in metastatic breast cancer with a triple-negative phenotype PDF
(Rus)
Vol 19, No 4 (2017) Articles Clinical and radiological evaluation the effectiveness of preoperative systemic therapy in different biological subtypes of breast cancer stages T1-3N0-1M0 PDF
(Rus)
Vol 19, No 4 (2017) Articles Soft tissue metastases of the gluteal region in HER2+ breast cancer: a clinical case PDF
(Rus)
Vol 20, No 1 (2018) Articles Ramucirumab therapy in patients with advanced gastric cancer: discussion of a case series PDF
(Rus)
Vol 20, No 1 (2018) Articles Dermatomyositis and polymyositis in breast cancer patients: a case reports PDF
(Rus)
Vol 13, No 1 (2011) Articles Opyt dlitel'nogo primeneniya kombinatsii kapetsitabina, lapatiniba i trastuzumabapri HER-2-pozitivnom metastaticheskom rake molochnoy zhelezy. Opisanie klinicheskogo sluchaya
Vol 13, No 4 (2011) Articles Antiangiogennaya terapiyapri rake molochnoy zhelezys troynym negativnym fenotipom
Vol 20, No 2 (2018) Articles Optimal duration of adjuvant trastuzumab therapy in patients with HER2-possitive early breast cancer: whether the problem is resolved? PDF
(Rus)
Vol 20, No 2 (2018) Articles Ribociclib in 1st line HR+ breast cancer treatment PDF
(Rus)

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies